Program of the 8th AMR Conference
Pre-conference meetings
Tuesday, 5 March 2024
Conference Day 1
Wednesday, 6 March 2024
Conference Day 2
Thursday, 7 March 2024
Pre-conference meetings
Tuesday, 5 March 2024 | Venue tbd
The pre-conference meetings are not an integral part of the AMR Conference. However, when registering for the conference, you can indicate your interest to participate. The organizers will inform you about the acceptance of your participation shortly before the conference.
09:30 – 15:30
Workshop – Phage Therapy: What’s New and What’s Next?
This interactive workshop aims to delve into the development of a sustainable phage therapy value chain, emphasizing the progress, challenges and opportunities in phage therapy. Sessions will be held on scientific developments, clinical research, and phage manufacturing. Participants will also explore intellectual property strategies and engage in discussions about the global regulatory landscape. In addition, the event will include start-up showcases and an investor panel to discuss funding options and investment strategies. The workshop provides a platform for experts, entrepreneurs, and investors to explore the future of phage therapy. Number of participants will be limited.
Organized by
Fully booked
16:00 – 18:00
Networking meeting
Organized by
Fully booked
Conference Day 1
Wednesday, 6 March 2024 | Congress Center Hall 4.0
09:00 – 11:00
BEAM Alliance General Assembly
Room Kairo
open only to members of the BEAM Alliance
09:30 – 11:00
Pre-conference workshop
Room Shanghai
Milestone-driven R&D – opportunities and challenges
Jointly organized by
Moderator:
Ursula Theuretzbacher (Center for Anti-Infective Agents)
Speakers:
Malcolm Page (Antibiotic Research): “Integrating TPPs and TCPs in discovery strategies”
Kenneth Bradley (F. Hoffmann-La Roche Ltd.): “Data driven decision making in antibiotics preclinical research”
11:30 – 13:00
Opening plenary
Room Shanghai
2024, a decisive year – Update on the AMR environment
Moderator:
Marc Gitzinger (BioVersys AG & BEAM Alliance)
Speakers:
Wolfgang Philipp (European Commission – DG HERA)
Jonathan Pearce (Antibiotic Research UK)
Judith Moore (World Economic Forum)
Alexandra Cameron (World Health Organization)
Zoe Molyneux (Wellcome Trust)
Alan Donnelly (G20 Health & Development Partnership)
13:00 – 13:15
Announcement of new CARB-X funding rounds
Room Shanghai
Themes and timeline of the new CARB-X funding rounds
Hosted by 
Speaker:
Erin Duffy (CARB-X)
13:15 – 14:00
Lunch break
14:00 – 15:30
Parallel sessions
Room Shanghai
Taking actions on pull incentives
Moderator:
Kevin Outterson (CARB-X & Boston University)
Speakers:
Pierre Dubois (Toulouse School of Economics)
Damiët Onderstal (European Commission – DG HERA)
Pietro Erba (European Commission – DG SANTE)
Jasper Claessen (Dutch Ministry of Health)
Simon Gottwalt (Swiss Federal Office of Public Health)
Room Delhi
Preclinical models to optimize translation to human
Moderator:
Martin Everett (Aurobac Therapeutics)
Speakers:
Ian Morrissey (Antimicrobial Focus Ltd.)
Caterina Bissantz
(F. Hoffmann-La Roche Ltd)
Coen van Hasselt (Leiden University)
Christopher Darlow (Liverpool University)
Markus Zeitlinger (Medical University of Vienna)
Nicolas Tesse (Septeos)
Room Kairo
Vaccines to keep AMR at bay
Moderator:
Marianne Holm (Novo Nordisk Foundation)
Speakers:
Ramanan Laxminarayan (One Health Trust)
Patricia Martin (LimmaTech Biologics AG)
Laura Plant (International Vaccine Institute)
Ed Buurman (CARB-X)
Mateusz Hasso-Agopsowicz (World Health Organization)
16:00 – 17:30
Parallel sessions
Room Shanghai
Meaningful clinical trials: combining regulatory and clinical differentiation needs
Moderator:
Glenn Dale (BioVersys AG)
Speakers:
Radu Botgros (European Medicines Agency)
Mark Jones (Basilea Pharmaceutica International Ltd)
Ulrich Granzer (Granzer Regulatory Services GmbH)
David Paterson (National University of Singapore)
Room Delhi
Novel disruptive approaches to fight AMR
Hosted by
Moderator:
Christoph Dehio (NCCR AntiResist)
Speakers:
Max Gutierrez (Francis Crick Institute)
Lucas Boeck (University of Basel)
Claudia Zampaloni
(F. Hoffmann-La Roche Ltd)
Room Kairo
How can AI foster prevention and smart use of antibiotics in a One Health world?
Supported by 
Moderator:
Lothar Wieler (Hasso Plattner Institute)
Speakers:
Ralf Sudbrak (Global AMR R&D Hub)
Lara Urban (Helmholtz Munich)
Thomas Van Boeckel (ETH Zurich)
Muna Abu-Sin (Robert Koch Institute)
Ramanan Laxminarayan (One Health Trust)
18:00 – 19:30
Start-up pitch
Room Shanghai
Hosted by
10’000 € award sponsored by
Moderator:
Douglas Häggström (INCATE)
Running order of pitching companies:
- TabriX (presented by Marc Creus)
- BrIgID Biologics (presented by Soumya Palliyil)
- BamA Inhibitor (presented by Till Schäberle)
- Microplate Dx (presented by Stuart Hannah)
- Omnicin Therapeutics (presented by Auke van Heel)
- Obulytix (presented by Yves Briers)
- Tolka AI Therapeutics (presented by Johan Wikstrom)
- Generare (presented by Guillaume Vandenesch)
- Theralia AB (presented by Baris Ata Borsa)
- Puray (presented by Martin Duffner)
- Smartbax (presented by Robert Macsics)
19:30 – 21:30
Evening reception
Conference Day 2
Thursday, 7 March 2024 | Congress Center Hall 4.0
08:30 – 09:30
Plenary session
Room Shanghai
A phage cocktail for breakfast?
Moderator:
Valeria Gigante (World Health Organization)
Speakers:
Mercedes Gonzalez Moreno (INCATE)
Alexander Belcredi (BioNTech R&D GmbH)
Thilo Köhler (University of Geneva)
Shawna McCallin (University Hospital Zurich)
10:00 – 11:30
Parallel sessions
Room Shanghai
Making the case for investing in AMR R&D
Moderator:
Marie Petit (Villiger Valuation)
Speakers:
Carly Levine (AMR Action Fund)
Marc Lemonnier (Antabio)
Guennnaelle Dieppois (F. Hoffmann-La Roche Ltd)
Zaki Sellam (Landmark BioVentures AG)
Room Delhi
Tuberculosis: new tools against an old enemy
Moderator:
Viorel Soltan (STOP TB Partnership)
Speakers:
Claire Jordan Brooks (University Carlos III Madrid)
Hoon Sang Lee (RIGHT Foundation)
Fuad Mirzayev (World Health Organization)
Nelly Badalato (Genoscreen)
Oxana Rucsineanu (Society of Moldova against Tuberculosis)
Room Kairo
New tricks to combat fungal infections
Moderator:
Mark Jones (Basilea Pharmaceutica International Ltd)
Speakers:
Dionysios Neofytos (University Hospitals Geneva)
Nina Khanna (University Hospital Basel)
Mai Hoang (Dynamic42 GmbH)
Mark Jones (Basilea Pharmaceutica International Ltd)
11:30 – 13:00
Lunch break
13:00 – 14:30
Parallel sessions
Room Shanghai
Push funding: a lifeline for R&D
Moderator:
Remko van Leeuwen (SurvivX)
Speakers:
Dennis Dixon (NIAID)
Clive Mason (LifeArc)
Alessandra Martini (European Commission – DG RTD)
Jean-Baptiste Perrin (European Commission – DG HERA)
Damiano de Felice (CARB-X)
Room Delhi
Fast, reliable and cost-effective diagnostics
Hosted by
Moderator:
Jens Hellwage (InfectoGnostics)
Speakers:
Milovan Stankov-Puges
(NG Biotech)
Adrian Egli (University of Zurich)
Rafael Cantón (Ramon y Cajal Hospital)
Giulia Pilla (Nostics)
Surbhi Malhotra (University of Antwerp)
Betsy Wonderly-Trainor (CARB-X)
Room Kairo
The true value of antimicrobial products
Hosted by
Moderator:
Deepali Patel (AMR Action Fund)
Speakers:
Pierre Dubois (Toulouse School of Economics)
Sophie Cooper (NICE)
Jennifer Quinn (Debiopharm)
Michele Cecchini (OECD)
Rachel Freeman (IQVIA)
Maria Larsson Ortino (Legal & General Investment Management)
15:00 – 16:30
Parallel sessions
Room Shanghai
Greatest reach to the greatest need
Moderator:
Jennifer Cohn (GARDP)
Speakers:
Alexandra Cameron (World Health Organization)
Mirfin Mpundu (ReAct)
Michael Anderson (MedAccess)
Yann Ferrisse (GARDP)
Brenda Waning (STOP TB Partnership)
Olivier Menzel (Swiss Agency for Development and Cooperation)
Room Delhi
Leveraging the power of diagnostics in clinical practice
Moderator:
Till Bachmann (University of Edinburgh)
Speakers:
Gail Hayward (University of Oxford)
Maarten Postma (University of Groningen)
Magda Rosenmöller (IESE Business School)
Gemma Johnson (OLM Diagnostics)
Toby Leslie (Mott MacDonald / The Fleming Fund)
Room Kairo
Technology update
Moderator:
Peter Jackson (Infex Therapeutics)
Speakers:
Susana Tomásio (Collaborative Drug Discovery)
John Cadwell (FiberCell Systems Inc.)
Hee-Jong Hwang (A&J Science)
Matti Jalasvuori (PrecisionPhage)
Colm Leonard (Infex Therapeutics)
17:00 – 18:00
Closing plenary
Room Shanghai
Multisectoral response to a multisectoral challenge
Moderator:
Florence Séjourné (Aurobac Therapeutics)
Speakers:
Cary Adams (Union for International Cancer Control UICC)
Pratik Bhatnagar (IQVIA)
Mark Albrecht (US Department of Health and Human Services)
Aanika Dalal (Alliance for Reducing Microbial Resistance ARMoR)
and presentation of the poster awards, kindly sponsored by Axxam
18:00 – 19:00
Farewell reception
BEAM Alliance program committee
Marc Gitzinger
Florence Séjourné
